StockWatch
·

Primo Chemicals Ltd

BSE: 506852

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
145.51
-3.3%-1.2%
Expenditure
136.65
-4.2%-2.5%
Net Profit
3.64
-28.6%+19.1%
OPM %
14.83%
+1.69pp+0.46pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-20.4329.4679.36129.26179.15Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Shareholding Trend

PromoterPublic
26%50%74%Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Latest News
Quarterly Result14 Aug, 5:13 pm

Primo Chemicals Q1 FY27: consolidated PAT +15% YoY as margins expand on flat revenue

Primo Chemicals reported consolidated revenue from operations of ₹140.28 Cr for Q1 FY27, down 1.2% YoY from ₹141.94 Cr and down 3.2% QoQ from ₹144.86 Cr — a broadly flat topline rather than a growth quarter. Consolidated net profit (after the associate-profit line) came in at ₹4.68 Cr, up 14.9% YoY from ₹4.08 Cr, though down 22.9% QoQ from ₹6.07 Cr in Q4 FY26 — the QoQ dip reflects a high base against a stronger prior quarter and should not be read as deterioration, since YoY the company grew profit well ahead of its (flat) revenue. The profit growth was margin-led: operating margin (EBITDA/revenue) expanded to 14.83% from 14.37% a year ago and from 13.14% in Q4 FY26, helped by contained materials and power costs (cost of materials consumed was ₹82.96 Cr versus ₹85.27 Cr a year ago on similar revenue). Net profit margin was 3.22%, up from 2.77% YoY but down from 4.04% QoQ. There were no exceptional items in either the current or year-ago quarter, so the YoY profit growth is entirely underlying, with no one-off adjustment required. Standalone and consolidated results are near-identical at the operating level — revenue, total expenses and PBT of ₹8.86 Cr are the same in both statements — because Primo holds only a 49% stake in Flow Tech Chemicals and equity-accounts it as an associate rather than fully consolidating it. That associate contributed ₹1.04 Cr to consolidated PAT this quarter, which is why consolidated PAT (₹4.68 Cr) runs about 29% above standalone PAT (₹3.64 Cr) — a divergence worth flagging since readers will see the standalone number too. This relationship is in transition: the board approved (July 2, 2026) and shareholders cleared (August 5, 2026) converting the 49% stake into a controlling 51%+ stake, making Flow Tech Chemicals a wholly owned subsidiary; the company notes the paperwork was still being executed as of this filing, after which Flow Tech's financials would likely be line-item consolidated rather than appearing as a single associate-profit line. Management gives no formal guidance or outlook commentary in this filing, and our records show no prior guidance or concall read to check this result against. A web search for analyst previews or consensus estimates for Primo Chemicals returned no relevant coverage, consistent with this being a lightly-tracked small-cap; vsStreet is marked unknown rather than guessed. Other Q1 developments in our event records — the May 2026 ₹21 Cr solar power plant investment and routine insider-trading window/share-transfer disclosures — are not separately broken out in this result and show no discernible P&L impact this quarter.

14 Aug 2026, 05:13 pm

Corporate Events

Board MeetingPRIMO
2026
14Aug

Board Meeting

The meeting of the Board of Directors of the Company will be…

BSE Filing
Board MeetingPRIMO
2026
2Jul

Board Meeting

Board approved the acquisition of 51% equity stake in Flow T…

BSE Filing
Board MeetingPRIMO
2024
12Nov

Board Meeting

Approval Of The Unaudited Financial Results (Standalone & Co…

BSE Filing
Board MeetingPRIMO
2024
30May

Board Meeting

approve Audited Financial Results (Standalone & Consolidated…

BSE Filing
Board MeetingPRIMO
2024
9Feb

Board Meeting

consider and approve Unaudited Financial Results (Standalone…

BSE Filing
Board MeetingPRIMO
2023
4Nov

Board Meeting

Approval of Unaudited Financial Results (Standalone & Consol…

BSE Filing
Board MeetingPRIMO
2023
14Aug

Board Meeting

Consider and approve Unaudited Financial Results (Standalone…

BSE Filing